Integra LifeSciences Holdings’ (NASDAQ:IART) earnings have declined over three years, contributing to shareholders 48% loss

Date:

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you try your hand at stock picking, your risk returning less than the market. Unfortunately, that’s been the case for longer term Integra LifeSciences Holdings Corporation (NASDAQ:IART) shareholders, since the share price is down 48% in the last three years, falling well short of the market return of around 23%. And more recent buyers are having a tough time too, with a drop of 38% in the last year. Furthermore, it’s down 19% in about a quarter. That’s not much fun for holders.

While the last three years has been tough for Integra LifeSciences Holdings shareholders, this past week has shown signs of promise. So let’s look at the longer term fundamentals and see if they’ve been the driver of the negative returns.

View our latest analysis for Integra LifeSciences Holdings

There is no denying that markets are sometimes…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...